Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
Mr. Halstead is currently serving as Executive Vice President and General Counsel.
- Mr. Halstead is currently serving as Executive Vice President and General Counsel.
- In this newly created leadership role, Mr. Halstead will oversee several functions within the Company including legal, human resources, manufacturing & supply chain, quality, compliance, information technology, and external innovation.
- “Michael is an exceptional leader who has been instrumental in Intra-Cellular Therapies’ strong growth over the last decade,” said Dr. Sharon Mates, Chairman and CEO of Intra-Cellular Therapies.
- He joined Intra-Cellular Therapies in 2014 as Senior Vice President and General Counsel and was promoted to Executive Vice President and General Counsel in 2019.